Abstract
Various quantitative strategies can be utilized in mass spectrometry (MS)-based proteomic investigations. Here we explore recent applications of quantitative MS-based strategies and the resulting advances in the areas of prostate, pancreatic, breast and ovarian cancer research.
Funding Information
  • National Cancer Institute (U01CA231081)
  • National Institute of General Medical Sciences (P41GM108538)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK071801)
  • National Institute on Aging (RF1 AG052324)
  • Wisconsin Alumni Research Foundation

This publication has 148 references indexed in Scilit: